Evaluation of the Effectiveness, Safety, and Tolerability of Tapentadol PR Versus a Combination of Tapentadol PR and Pregabalin in Subjects With Severe Chronic Low Back Pain With a Neuropathic Pain Component.
Phase of Trial: Phase IV
Latest Information Update: 23 Aug 2016
At a glance
- Drugs Tapentadol (Primary) ; Pregabalin
- Indications Back pain
- Focus Therapeutic Use
- Sponsors Grunenthal
- 09 Aug 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
- 03 Mar 2012 This trial has been completed in Netherlands, Denmark, Spain and Austria.
- 16 Nov 2011 Planned patient number is 800 as reported by European Clinical Trials Database record.